PAVmed (PAVM) Competitors $0.44 -0.03 (-5.49%) Closing price 03:59 PM EasternExtended Trading$0.46 +0.02 (+4.68%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. RBOT, MODD, NMTC, POCI, TMDIF, CLGN, VVOS, DRIO, RVP, and COCHShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Vicarious Surgical (RBOT), Modular Medical (MODD), NeuroOne Medical Technologies (NMTC), Precision Optics (POCI), Titan Medical (TMDIF), CollPlant Biotechnologies (CLGN), Vivos Therapeutics (VVOS), DarioHealth (DRIO), Retractable Technologies (RVP), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry. PAVmed vs. Its Competitors Vicarious Surgical Modular Medical NeuroOne Medical Technologies Precision Optics Titan Medical CollPlant Biotechnologies Vivos Therapeutics DarioHealth Retractable Technologies Envoy Medical PAVmed (NASDAQ:PAVM) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Which has higher earnings & valuation, PAVM or RBOT? PAVmed has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPAVmed$2.99M3.26$39.79M$1.160.38Vicarious SurgicalN/AN/A-$63.22M-$10.09-0.56 Which has more volatility & risk, PAVM or RBOT? PAVmed has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Do analysts rate PAVM or RBOT? PAVmed currently has a consensus price target of $19.00, suggesting a potential upside of 4,177.35%. Vicarious Surgical has a consensus price target of $7.00, suggesting a potential upside of 22.91%. Given PAVmed's stronger consensus rating and higher possible upside, research analysts plainly believe PAVmed is more favorable than Vicarious Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Vicarious Surgical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders and institutionals hold more shares of PAVM or RBOT? 19.9% of PAVmed shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 7.3% of PAVmed shares are owned by insiders. Comparatively, 12.0% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is PAVM or RBOT more profitable? PAVmed has a net margin of 7,144.80% compared to Vicarious Surgical's net margin of 0.00%. PAVmed's return on equity of 0.00% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets PAVmed7,144.80% N/A -20.96% Vicarious Surgical N/A -148.14%-98.07% Does the media refer more to PAVM or RBOT? In the previous week, Vicarious Surgical had 2 more articles in the media than PAVmed. MarketBeat recorded 2 mentions for Vicarious Surgical and 0 mentions for PAVmed. Vicarious Surgical's average media sentiment score of 0.78 beat PAVmed's score of 0.00 indicating that Vicarious Surgical is being referred to more favorably in the news media. Company Overall Sentiment PAVmed Neutral Vicarious Surgical Positive SummaryPAVmed beats Vicarious Surgical on 10 of the 15 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PAVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.31M$6.90B$5.75B$9.85BDividend YieldN/A1.22%6.67%4.51%P/E Ratio0.3826.0678.4326.42Price / Sales3.2670.07546.94119.09Price / CashN/A21.6037.0558.92Price / Book-0.484.9010.916.06Net Income$39.79M$178.27M$3.29B$266.28M7 Day Performance-5.09%-0.61%0.01%-0.76%1 Month Performance-15.57%1.88%7.06%3.83%1 Year Performance-59.62%9.93%50.09%24.39% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.4385 of 5 stars$0.44-5.5%$19.00+4,177.4%-60.4%$10.31M$2.99M0.3890RBOTVicarious Surgical1.7024 of 5 stars$6.76+0.3%$7.00+3.6%+4.0%$39.97MN/A-0.67210MODDModular Medical0.8593 of 5 stars$0.76+5.6%N/A-61.0%$39.80MN/A-1.4920Gap DownNMTCNeuroOne Medical Technologies1.7118 of 5 stars$0.78-0.5%$1.45+85.8%-6.3%$39.23M$3.45M-5.2020Negative NewsShort Interest ↑POCIPrecision OpticsN/A$4.85-2.0%N/A-17.1%$37.95M$19.10M-5.4580Gap DownTMDIFTitan MedicalN/A$0.31-12.9%N/A+811.4%$35.66M$17.63M-0.2550CLGNCollPlant Biotechnologies2.9033 of 5 stars$2.63+4.4%$11.50+337.3%-49.4%$32.04M$510K-2.3370Short Interest ↓VVOSVivos Therapeutics0.3029 of 5 stars$4.63+10.2%$4.82+4.0%+73.9%$31.52M$14.39M-2.76160DRIODarioHealth1.9278 of 5 stars$0.55-3.5%$2.00+263.6%-43.3%$25.94M$27.04M-0.83200Stock SplitHigh Trading VolumeRVPRetractable Technologies2.9121 of 5 stars$0.85+1.8%N/A-14.7%$25.33M$38.16M-1.57240Positive NewsShort Interest ↓COCHEnvoy Medical2.5286 of 5 stars$1.12-2.6%$9.25+725.9%-60.1%$24.75M$220K-0.7834Analyst Revision Related Companies and Tools Related Companies Vicarious Surgical Competitors Modular Medical Competitors NeuroOne Medical Technologies Competitors Precision Optics Competitors Titan Medical Competitors CollPlant Biotechnologies Competitors Vivos Therapeutics Competitors DarioHealth Competitors Retractable Technologies Competitors Envoy Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PAVM Stock Alerts